Seufferlein, Thomas

Publishing since 1994 (Senior)

Has published 63 publications in 17 years

Number of publications published per year by Seufferlein, Thomas. (Source : PubMed)

Distribution of publications types for Seufferlein, Thomas. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Walldorf J, Hillebrand C, Aurich H, Stock P, Hempel M, Ebensing S, Fleig WE, Seufferlein T, Dollinger MM, Christ B. Propranolol impairs liver regeneration after partial hepatectomy in C57Bl/6-mice by transient attenuation of hepatic lipid accumulation and increased apoptosis.  Scand. J. Gastroenterol.  2010;45;4  
•  Krndija D, Schmid H, Eismann JL, Lother U, Adler G, Oswald F, Seufferlein T, von Wichert G. Substrate stiffness and the receptor-type tyrosine-protein phosphatase alpha regulate spreading of colon cancer cells through cytoskeletal contractility.  Oncogene  2010  
•  Schmiegel W, Pox C, Reinacher-Schick A, Adler G, Arnold D, Fleig W, Fölsch UR, Frühmorgen P, Graeven U, Heinemann V, Hohenberger W, Holstege A, Junginger T, Kopp I, Kühlbacher T, Porschen R, Propping P, Riemann JF, Rödel C, Sauer R, Sauerbruch T, Schmitt W, Schmoll HJ, Seufferlein T, Zeitz M, Selbmann HK. S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII).  Z Gastroenterol  2010;48;1  
•  Moehler M, Kanzler S, Geissler M, Raedle J, Ebert MP, Daum S, Flieger D, Seufferlein T, Galle PR, Hoehler T. A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagogastric junction.  Ann. Oncol.  2010;21;1  
•  Rolli CG, Seufferlein T, Kemkemer R, Spatz JP. Impact of tumor cell cytoskeleton organization on invasiveness and migration: a microchannel-based approach.  PLoS ONE  2010;5;1  
•  Seufferlein T, Adler G. [The S3 guideline exocrine pancreatic cancer]  Med. Klin. (Munich)  2009;104;11  
•  Porzner M, Müller T, Seufferlein T. SR 57746A/xaliproden, a non-peptide neurotrophic compound: prospects and constraints for the treatment of nervous system diseases.  Expert Opin Investig Drugs  2009;18;11  
•  Schneiderhan W, Scheler M, Holzmann KH, Marx M, Gschwend JE, Bucholz M, Gress TM, Seufferlein T, Adler G, Oswald F. CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models.  Gut  2009;58;10  
•  Lübbert C, Taege C, Seufferlein T, Grunow R. [Prolonged course of tick-borne ulceroglandular tularemia in a 20-year-old patient in Germany--case report and review of the literature]  Dtsch. Med. Wochenschr.  2009;134;27  
•  Lübbert C, Albert JG, Hainz M, Pudszuhn A, Seufferlein T. [Tonsillar actinomycosis as a rare cause of oral malodor. Diagnosis beyond a gastroenterologist's nose]  Med. Klin. (Munich)  2009;104;6  

[ See timeline ] [ See all publications ]